In non-small cell lung cancer (NSCLC), a high lung cancer activation module score, which is determined by activated T cells, IgG+ plasma cells, and SPP1+ macrophages, correlated with enhanced response to immunotherapy [12]. Here, SPP1 is linked to non-small cell lung carcinoma.